Suggestions

Du même auteur

Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease

Archive ouverte | Ko, Wai Kin D. | CCSD

International audience. Amantadine, an N-methyl-D-aspartate glutamate receptor antagonist, is currently the only pharmacological treatment for levodopa-induced dyskinesia (LID) in Parkinson's disease (PD), but cause...

Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury

Archive ouverte | Squair, Jordan | CCSD

International audience

RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease

Archive ouverte | Gold, Stephen J. | CCSD

International audience. Chronic l-dopa treatment of Parkinson's disease (PD) often leads to debilitating involuntary movements, termed l-dopa-induced dyskinesia (LID), mediated by dopamine (DA) receptors. RGS9–2 is ...

Chargement des enrichissements...